MCI
RPRX icon

MRP Capital Investments’s Royalty Pharma RPRX Stock Holding History

MRP Capital Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,200
Closed -$317K – 223
2025
Q4 		$317K Buy
8,200
+3,900
+91% +$149K 0.27% 74
2025
Q3 		$155K Hold
4,300
– – 0.13% 101
2025
Q2 		$155K Buy
4,300
+180
+4% +$5.96K 0.11% 92
2025
Q1 		$128K Hold
4,120
– – 0.12% 105
2024
Q4 		$105K Sell
4,120
-2,000
-33% -$53K 0.1% 104
2024
Q3 		$173K Buy
+6,120
New +$170K 0.16% 98
2023
Q3 		– Sell
-7,200
Closed -$221K – 189
2023
Q2 		$221K Buy
7,200
+200
+3% +$6.77K 0.22% 100
2023
Q1 		$252K Hold
7,000
– – 0.28% 79
2022
Q4 		$277K Buy
+7,000
New +$292K 0.31% 74

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return